盘点:2019年6月15日BMJ研究精选

2019-06-18 MedSci MedSci原创

BMJ

2019年6月15日BMJ研究精选



【1】红肉摄入变化与总体和特定死亡率的关系


近日研究人员旨在评估红肉摄入变化与女性和男性总死亡率和原因特定死亡率之间的关系。

参与者为在基线时无心血管疾病或癌症的53553名女性和27916名男性。在120万人次的随访期间发生了14019例死亡。8年内红肉摄入量的增加与随后8年中女性和男性的死亡风险增加相关。红肉总摄入量每天增加至少半份与死亡风险增加10%相关。对于加工和未加工的红肉摄入量,每天至少增加半份的死亡风险分别增加13%和死亡风险增加9%。每天加工或未加工红肉的摄入量减少至少半份与死亡率风险无关。

【2】加巴喷丁、普瑞巴林与神经精神系统障碍


近日研究人员考察了加巴喷汀类药物与协调障碍(头部、身体伤害或道路交通事故)、精神健康(自杀行为、非故意用药过量)和犯罪等不良事件的关系。

在研究期间,10026(5.2%)名参与者因自杀行为接受治疗或死于自杀,17144(8.9%)名参与者出现过量服药,12070(6.3%)名参与者出现道路交通事故或犯罪,70522(36.7%)名参与者出现头部或身体受伤,7984(4.1%)名参与者因暴力犯罪被捕。在个体分析中,加巴喷丁治疗导致自杀行为和自杀死亡(年龄调整后的危险比为1.26)、药物过量(1.24)、头部/身体伤害(1.22)和道路交通事故和犯罪(1.13)风险增加。单独检查药物时,普瑞巴林与所有结果的危险性增加相关,而加巴喷丁的相关性不显著。当按年龄分层时,15-24岁人群风险增加最为显著。

【3】冠状动脉CT血管造在冠心病诊断中的应用


近日研究人员探讨了冠状动脉CT血管造影(CTA)对冠心病(CAD)患者诊断的影响。

本次研究为系统综述和荟萃分析研究,将冠状动脉CTA与冠状动脉造影进行比较,总计包含65项研究, 5332名患者数据。在7%的预测概率下,CTA的阳性预测值为50.9%,阴性预测值为97.8%;67%的预测概率下,分别上升为82.7%和85.0%。CTA诊断的敏感性和特异性较高,但女性诊断能力略低于男性。CTA的诊断性能在75岁以上患者(0.864)中下降,但不受疾病类型的影响。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1848767, encodeId=46781848e6756, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 11 05:02:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369076, encodeId=82753690e650, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Fri Jul 05 06:57:52 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368393, encodeId=8fd33683934f, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Wed Jun 26 17:34:48 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367994, encodeId=9f1536e994fd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ae12072513, createdName=1381f06c43m, createdTime=Wed Jun 19 07:39:33 CST 2019, time=2019-06-19, status=1, ipAttribution=)]
    2020-05-11 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1848767, encodeId=46781848e6756, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 11 05:02:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369076, encodeId=82753690e650, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Fri Jul 05 06:57:52 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368393, encodeId=8fd33683934f, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Wed Jun 26 17:34:48 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367994, encodeId=9f1536e994fd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ae12072513, createdName=1381f06c43m, createdTime=Wed Jun 19 07:39:33 CST 2019, time=2019-06-19, status=1, ipAttribution=)]
    2019-07-05 百草

    666

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1848767, encodeId=46781848e6756, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 11 05:02:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369076, encodeId=82753690e650, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Fri Jul 05 06:57:52 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368393, encodeId=8fd33683934f, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Wed Jun 26 17:34:48 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367994, encodeId=9f1536e994fd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ae12072513, createdName=1381f06c43m, createdTime=Wed Jun 19 07:39:33 CST 2019, time=2019-06-19, status=1, ipAttribution=)]
    2019-06-26 百草

    666

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1848767, encodeId=46781848e6756, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 11 05:02:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369076, encodeId=82753690e650, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Fri Jul 05 06:57:52 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368393, encodeId=8fd33683934f, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Wed Jun 26 17:34:48 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367994, encodeId=9f1536e994fd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ae12072513, createdName=1381f06c43m, createdTime=Wed Jun 19 07:39:33 CST 2019, time=2019-06-19, status=1, ipAttribution=)]
    2019-06-19 1381f06c43m

    学习了

    0

相关资讯

盘点:2019年5月18日BMJ研究精选

2019年5月18日BMJ研究精选

盘点:2019年5月25日BMJ研究精选

2019年5月25日BMJ研究精选

盘点:2019年5月4日BMJ研究精选

2019年5月4日BMJ研究精选

盘点:2019年6月8日BMJ研究精选

2019年6月8日BMJ研究精选

盘点:2019年6月1日BMJ研究精选

2019年6月1日BMJ研究精选

盘点:2019年5月11日BMJ研究精选

2019年5月11日BMJ研究精选